Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand Read more about Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand US Application 62/820,604Filed on 2019-03-19
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION US Application 63/177,570Filed on 2021-04-21
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors Read more about High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US Application 62/924,498Filed on 2019-10-22
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US Application 62/900,240Filed on 2019-09-13
INHIBITORS OF HISTONE DEMETHYLASES Read more about INHIBITORS OF HISTONE DEMETHYLASES US Application 62/936,722Filed on 2019-11-18
METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE Read more about METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE US Application 62/981,382Filed on 2020-02-25
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains Read more about Chimeric Antigen Receptors Containing Glypican 2 Binding Domains US Application 62/876,483Filed on 2019-07-19
A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA Read more about A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA US Application 62/914,138Filed on 2019-10-11
PEGYLATED RECOMBINANT IMMUNOTOXINS Read more about PEGYLATED RECOMBINANT IMMUNOTOXINS US Application 62/935,822Filed on 2019-11-15
HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs) Read more about HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs) US Application 62/963,856Filed on 2020-01-21